Factors Associated with Methamphetamine Withdrawal Symptoms Among People Who Inject Drugs


Contributed to by PISC External Advisory Board member Ricky Bluthenthal, PhD, this study examines the prevalence and predictors of methamphetamine (MA) withdrawal symptoms among people who inject drugs (PWID). Despite growing literature in the field, the authors find that no studies have yet tackled such a topic. After recruiting PWID in Los Angeles and San Francisco, California from 2016-2017, the study used multivariable regression models on survey responses to find that MA withdrawal symptoms in the past 6 months were reported by 53% of PWID. It also found that receptive syringe sharing was associated any any withdrawal symptoms, and female PWID were associated with greater withdrawal symptoms, indicating that such groups are potential targets for future programs.


Go to Article

Back to News